| Insideraktier | 69.568.637 shares |
Insider-stemningsscore
Insider Sentiment Score viser, at virksomhederne bliver købt af virksomheders insidere.
Det er resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af insider-akkumulering. Scoringsmodellen bruger en kombination af nettoantallet af insidere, der har købt de foregående 90 dage, det samlede antal aktier købt som en procentdel af float og det samlede antal aktier ejet af insidere. Tallet går fra 0 til 100, hvor højere tal indikerer et højere niveau af akkumulering for sine jævnaldrende, og 50 er gennemsnittet.
Opdateringsfrekvens: Dagligt
Se Insiders Top Picks, som giver en liste over virksomheder med den højeste insider-akkumulering.
Officers sentiment score
Officer Sentiment Score finder virksomheder, der bliver købt af Corporate Officers.
Per definition er Corporate Officers Corporate Insiders, men i modsætning til nogle af de andre Insiders (10 % aktionærer og bestyrelsesmedlemmer), arbejder officerer for virksomheden på daglig basis, og de bruger deres egne penge, når de handler . (10 % aktionærer og bestyrelsesmedlemmer er ofte fondsforvaltere, der administrerer andres penge.) Som sådan er insiderhandler foretaget af embedsmænd meget mere betydningsfulde og bør behandles passende.
Ligesom Insider Sentiment Score er Officer Sentiment Score resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af officerakkumulering.
Opdateringsfrekvens: Dagligt
Se Insiders Top Picks, som giver en liste over virksomheder med højeste insider-stemning.
Nøgle Insider Metrics
Dette kort viser, hvordan virksomheden rangerer langs forskellige insider-metrics. Percentilrangen viser, hvordan denne virksomhed sammenligner sig med andre virksomheder på de amerikanske markeder. Højere placeringer er tegn på bedre situationer.
For eksempel er det generelt accepteret, at insider-køb er en positiv indikator, så virksomheder med flere insider-køb vil rangere højere end virksomheder med mindre insider-køb (eller endda insider-salg).
Netto antal insidere, der køber (rang)
N/A
Netto antal insidere, der køber, er det samlede antal insiders, der køber minus det samlede antal insiders, der har solgt inden for de sidste 90 dage. Percentilrangen vises her (spænder fra 0 til 100%).
Procent af float købt af insidere (rangering)
N/A
Procent af float købt af insidere er det samlede antal aktier købt af insidere minus det samlede antal aktier solgt af insidere inden for de sidste 90 dage, divideret med den samlede float og ganget med 100.
Insiderhandelsdiagram
Environmental Impact Acquisition Corp - Class A insiderhandler er vist i følgende diagram. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Generelt er det generelt ulovligt for insidere at foretage handler i deres virksomheder baseret på væsentlige, ikke-offentlige oplysninger. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4.
Insiderliste og lønsomhedsmålinger
Denne tabel viser listen over kendte insidere og genereres automatisk fra arkiveringer, der er videregivet til SEC. Ud over navnene, den seneste titel og direktør, officer eller 10 % ejerbetegnelse giver vi de seneste offentliggjorte besiddelser. Derudover giver vi, når det er muligt, den historiske handelspræstation for insideren. Den historiske handelspræstation er et vægtet gennemsnit af præstationen af faktiske købstransaktioner på det åbne marked foretaget af insideren. For mere information om, hvordan dette beregnes, se dette YouTube-webinar.
See our leaderboard of most profitable insider traders.
| Insider | Gennemsnitlig fortjeneste (%) | Aktier Ejet |
Dele Justeret |
|---|
Report errors via our new Insider Auditing Tool
Track Records af insiderkøb - Kortsigtet profitanalyse
I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i ENVI / Environmental Impact Acquisition Corp - Class A. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .
Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.
Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.
Track Records af insidersalg - Kortsigtet tabsanalyse
I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i ENVI / Environmental Impact Acquisition Corp - Class A. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .
Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.
| Handelsdato | Insider | Rapporteret Aktier |
Rapporteret Pris |
Justeret Aktier |
Justeret Pris |
Omkostningsgrundlag | dage til Min |
Pris kl Min |
Max tab Undgået ($) |
Max tab Undgået (%) |
|---|---|---|---|---|---|---|---|---|---|---|
| 2023-07-20 | Cormorant Asset Management, LLC | 9.188.659 | 0,0000 | 9.188.659 | 0,0000 | 0 | 1 | 0.2995 | 2.752.003 |
Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.
Transaktionshistorik
Klik på linkikonet for at se den fulde transaktionshistorik. Transaktioner, der rapporteres som en del af en automatisk handelsplan 10b5-1, vil have et X i kolonnen markeret 10b-5.
| Fil Dato |
Handle Dato |
Form | Insider | Ticker | Sikkerhedstitel | Kode | Direkte | Dyrke motion Pris |
Enhed Pris |
Enheder Ændret |
Værdi Ændret (1K) |
Tilbage Muligheder |
Tilbage Aktier |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-07-27 | 2023-07-24 | 4 | KODIAK VENTURE PARTNERS III LP | GRNA | Common Stock, par value $0.0001 per share | D | -9.809.895 | 0 | ||||||
| 2023-07-27 | 3 | KODIAK VENTURE PARTNERS III LP | GRNA | Common Stock | D | 9.809.895 | ||||||||
| 2023-07-27 | 2023-07-24 | 4 | Clarke Dennis A. | GRNA | Common Stock, par value $0.0001 per share | D | 0,0001 | 25.510 | 0 | 0 | ||||
| 2023-07-27 | 2023-07-24 | 4 | Anderson Eric Senior | GRNA | Common Stock, par value $0.0001 per share | D | 0,0001 | -25.510 | -0 | 0 | ||||
| 2023-07-27 | 2023-07-24 | 4 | Cummings Foundation, Inc. | GRNA | Common Stock, par value $0.0001 per share | D | 0,0001 | -1.275.510 | -0 | 0 | ||||
| 2023-07-26 | 2023-07-24 | 4 | COONEY CHARLES L | GRNA | Common Stock | D | 0,3000 | -305.314 | -92 | 0 | ||||
| 2023-07-26 | 2023-07-24 | 4 | Insud Pharma S.L. | GRNA | Common Stock, par value $0.0001 per share | D | -2.551.020 | 0 | ||||||
| 2023-07-26 | 3 | MLS Capital Fund II LP | GRNA | Common Stock, par value $0.0001 per share | D | 5.818.575 | ||||||||
| 2023-07-26 | 2023-07-24 | 4 | MLS Capital Fund II LP | GRNA | Common Stock, par value $0.0001 per share | D | -5.818.575 | 0 | ||||||
| 2023-07-26 | 2023-07-24 | 4 | PATRICK DEVAL L | GRNA | Common Stock, par value $0.0001 per share | D | -172.500 | 0 | ||||||
| 2023-07-26 | 2023-07-24 | 4 | Schlicher Martha | GRNA | Common Stock | D | 0,3000 | -109.218 | -33 | 0 | ||||
| 2023-07-26 | 2023-07-24 | 4 | Ortega-Valle Marta | GRNA | Common Stock | D | -29.798 | 0 | ||||||
| 2023-07-26 | 2023-07-24 | 4 | Zarur Juan Andrey | GRNA | Common Stock | D | 0,3000 | -896.058 | -269 | 0 | ||||
| 2023-07-26 | 2023-07-24 | 4 | Aulisa Lorenzo | GRNA | Common Stock, par value $0.0001 | D | -2.697 | 0 | ||||||
| 2023-07-26 | 2023-07-24 | 4 | Lewis & Clark Ventures I, LP | GRNA | Common Stock, par value $0.0001 per share | D | -557.632 | 0 | ||||||
| 2023-07-26 | 2023-07-24 | 4 | Walker Matthew Alan By Builders Vision, LLC | GRNA | Common Stock | I | -22.348.123 | 0 | ||||||
| 2023-07-26 | 2023-07-24 | 4 | Walker Matthew Alan | GRNA | Common Stock | D | -63.775 | 0 | ||||||
| 2023-07-26 | 2023-07-24 | 4 | Lewis & Clark Plant Sciences Fund I, LP | GRNA | Common Stock, par value $0.0001 per share | D | -1.816.746 | 0 | ||||||
| 2023-07-26 | 2023-07-24 | 4 | DHAMANKAR HIMANSHU HEMANT | GRNA | Common Stock, par value $0.0001 per share | D | -27.255 | 0 | ||||||
| 2023-07-26 | 2023-07-24 | 4 | Boscolo Intervest Ltd | GRNA | Common Stock, par value $0.0001 per share | D | -1.520.408 | 0 | ||||||
| 2023-07-26 | 2023-07-24 | 4 | ALEXANDRIA REAL ESTATE EQUITIES INC By Alexandria Venture Investments, LLC | GRNA | Common Stock | I | -1.609.909 | 0 | ||||||
| 2023-07-26 | 2023-07-24 | 4 | Chelt Trading Ltd | GRNA | Common Stock, par value $0.0001 per share | I | -1.520.408 | 0 | ||||||
| 2023-07-26 | 2023-07-24 | 4 | RUETTGERS MICHAEL C | GRNA | Common Stock | I | -206.629 | 0 | ||||||
| 2023-07-26 | 2023-07-24 | 4 | Iwuchukwu Ifeyinwa Jane | GRNA | Common Stock, par value $0.0001 per share | D | -14.886 | 0 | ||||||
| 2023-07-26 | 2023-07-24 | 4 | Prelude Ventures LLC | GRNA | Common Stock | I | -3.189.151 | 0 | ||||||
| 2023-07-26 | 2023-07-24 | 4 | CONTINENTAL GRAIN CO | GRNA | Greenlight Biosciences common stock | I | -6.489.242 | 0 | ||||||
| 2023-07-26 | 2023-07-24 | 4 | RAMACHANDRIYA DHARMAN KARTHIKEYAN | GRNA | Common Stock, par value $0.0001 per share | D | -47.000 | 0 | ||||||
| 2023-07-26 | 2023-07-24 | 4 | Sage Hill Investors, LLC | GRNA | Common Stock, par value $.0001 per share | D | -1.000.000 | 0 | ||||||
| 2023-07-26 | 2023-07-24 | 4 | Steinberg Michael | GRNA | Common Stock, par value $0.0001 per share | D | -91.842 | 0 | ||||||
| 2023-07-26 | 2023-07-24 | 4 | Serum Life Sciences Ltd | GRNA | Common Stock, par value $0.0001 per share | D | -1.000.000 | 0 | ||||||
| 2023-07-26 | 2023-07-24 | 4 | Sagar Rosemary | GRNA | Common Stock, par value $0.0001 per share | D | -208.704 | 0 | ||||||
| 2023-07-26 | 2023-07-24 | 4/A | Series Greenlight, a separate series of BlueIO Growth LLC | GRNA | Common Stock, par value $0.0001 per share | D | -500.890 | 0 | ||||||
| 2023-07-26 | 2023-07-24 | 4/A | Series Greenlight 2, a separate series of BlueIO Growth LLC | GRNA | Common Stock, par value $0.0001 per share | D | -569.423 | 0 | ||||||
| 2023-07-26 | 2023-07-24 | 4 | FURNEAUX CAPITAL HOLDCO, LLC | GRNA | Common Stock, par value $0.0001 per share | D | -125.221 | 0 | ||||||
| 2023-07-26 | 2023-07-24 | 4 | Velocity Financial Group, LLC | GRNA | Common Stock, par value $0.0001 per share | D | -292.186 | 0 | ||||||
| 2023-07-26 | 2023-07-24 | 4 | Series Greenlight 2, a separate series of BlueIO Growth LLC | GRNA | Common Stock, par value $0.0001 per share | D | 569.423 | 0 | ||||||
| 2023-07-26 | 2023-07-24 | 4 | Series Greenlight, a separate series of BlueIO Growth LLC | GRNA | Common Stock, par value $0.0001 per share | D | -500.890 | 0 | ||||||
| 2023-07-25 | 2023-07-24 | 4 | Richard Roger David | GRNA | Common Stock, par value $0.0001 per share | D | -69.888 | |||||||
| 2023-07-25 | 2023-07-24 | 4 | Gillian Jason Michael | GRNA | Common stock, par value $0.0001 per share | D | -28.732 | 0 | ||||||
| 2023-07-25 | 3 | RPB VENTURES LLC | GRNA | Common Stock | D | 300.000 | ||||||||
| 2023-07-25 | 2023-07-24 | 4 | Morningside Venture Investments Ltd | GRNA | Common Stock | D | -16.919.155 | 0 | ||||||
| 2023-07-25 | 2023-07-20 | 4 | Skizim Nicholas John | GRNA | Common Stock, par value $0.0001 per share | D | -26.965 | 0 | ||||||
| 2023-07-24 | 2023-07-24 | 4 | Xeraya Cove Ltd | GRNA | Common Stock | I | -1.734.277 | 0 | ||||||
| 2023-07-24 | 2023-07-20 | 4 | Cormorant Asset Management, LLC See Footnotes | GRNA | Common Stock | I | -9.188.659 | 0 | ||||||
| 2023-07-24 | 2023-07-20 | 4 | Tao Invest III LLC | GRNA | Common Stock, par value $0.0001 per share | D | -834.817 | 0 | ||||||
| 2023-07-24 | 2023-07-20 | 4 | Tao Invest V LLC | GRNA | Common Stock, par value $0.0001 per share | D | -1.836.847 | 0 | ||||||
| 2023-07-24 | 2023-07-20 | 4 | New Stuff Deux, LLC | GRNA | Common Stock, par value $0.0001 per share | D | -306.122 | 0 | ||||||
| 2023-07-24 | 2023-07-20 | 4 | New Stuff, LLC | GRNA | Common Stock, par value $0.0001 per share | D | -500.000 | 0 | ||||||
| 2023-06-20 | 3 | Sage Hill Investors, LLC | GRNA | Common Stock, par value $.0001 per share | D | 1.000.000 | ||||||||
| 2023-06-20 | 3 | Fall Line Endurance Fund, LP | GRNA | Common Stock, par value $0.0001 per share | D | 11.452.834 | ||||||||
| 2023-06-16 | 3 | Lurantos Maria Helena | GRNA | Common Stock CUSIP # 39536G 105 par value $0.00001 per share | D | 4.015 | ||||||||
| 2023-06-12 | 3 | Zahir Fares | GRNA | Common Stock | I | 1.734.277 | ||||||||
| 2023-06-09 | 3 | Chelt Trading Ltd Sole Shareholder of Boscolo Intervest Limited | GRNA | Common Stock, par value $0.0001 per share | I | 1.520.408 | ||||||||
| 2023-06-08 | 3 | Lewis & Clark Plant Sciences Fund I, LP | GRNA | Common Stock, par value $0.0001 per share | D | 1.816.746 | ||||||||
| 2023-06-08 | 3 | Lewis & Clark Ventures I, LP | GRNA | Common Stock, par value $0.0001 per share | D | 557.632 | ||||||||
| 2023-06-08 | 3 | Prelude Fund, LP | GRNA | Common Stock | I | 3.189.151 | ||||||||
| 2023-06-08 | 3 | Insud Pharma S.L. | GRNA | Common Stock, par value $0.0001 per share | D | 2.551.020 | ||||||||
| 2023-06-08 | 3 | RUETTGERS MICHAEL C | GRNA | Common Stock | I | 206.629 | ||||||||
| 2023-06-08 | 3 | CONTI GREENLIGHT INVESTORS, L.P. | GRNA | Greenlight Biosciences common stock | I | 6.489.242 | ||||||||
| 2023-06-08 | 3 | Cormorant Private Healthcare Fund II, LP See Footnotes | GRNA | Common Stock | I | 9.188.659 | ||||||||
| 2023-06-08 | 3 | Highview Trust Sole Shareholder of Chelt Trading Limited | GRNA | Common Stock I , par value $0.0001 per share | I | 1.520.408 | ||||||||
| 2023-06-08 | 3 | Montealegre Lacayo Jaime Javier Trustee and Sole Beneficiary of The Highview Trust | GRNA | Common Stock, par value $0.0001 per share | I | 1.520.408 | ||||||||
| 2023-06-08 | 3 | Alexandria Venture Investments, LLC By Alexandria Venture Investments, LLC | GRNA | Common Stock | I | 1.609.909 | ||||||||
| 2023-06-08 | 3 | Boscolo Intervest Ltd | GRNA | Common Stock, par value $0.0001 per share | D | 1.520.408 | ||||||||
| 2023-06-08 | 3 | Senczuk Anna Maria | GRNA | Common Stock, par value $0.0001 per share | D | 9.984 | ||||||||
| 2023-06-08 | 3 | Tao Invest V LLC | GRNA | Common Stock, par value $0.0001 per share | D | 1.836.847 | ||||||||
| 2023-06-08 | 3 | Tao Invest III LLC | GRNA | Common Stock, par value $0.0001 per share | D | 834.817 | ||||||||
| 2023-06-08 | 3 | New Stuff Deux, LLC | GRNA | Common Stock, par value $0.0001 per share | D | 306.122 | ||||||||
| 2023-06-08 | 3 | New Stuff, LLC | GRNA | Common Stock, par value $0.0001 per share | D | 500.000 | ||||||||
| 2023-06-07 | 3 | Serum Life Sciences Ltd | GRNA | Common Stock, par value $0.0001 per share | D | 1.000.000 | ||||||||
| 2023-06-07 | 3 | Steinberg Michael | GRNA | GreenLight Biosciences Holdings, PBC | D | 91.842 | ||||||||
| 2023-06-07 | 3 | Macadino Caitlin | GRNA | Common Stock, par value $0.0001 per share | D | 28.821 | ||||||||
| 2023-06-07 | 3 | Iwuchukwu Ifeyinwa Jane | GRNA | Common Stock, par value $0.0001 per share | D | 14.886 | ||||||||
| 2023-06-07 | 3 | Aulisa Lorenzo | GRNA | Common Stock, par value $0.0001 per share | D | 2.697 | ||||||||
| 2023-06-07 | 3 | DHAMANKAR HIMANSHU HEMANT | GRNA | Common stock, par value $0.0001 per share | D | 27.255 | ||||||||
| 2023-06-07 | 3 | RAMACHANDRIYA DHARMAN KARTHIKEYAN | GRNA | Common Stock, par value $0.0001 per share | D | 47.000 | ||||||||
| 2023-06-07 | 3 | Richard Roger David | GRNA | Common Stock, par value $0.0001 per share | D | 69.888 | ||||||||
| 2023-06-06 | 3 | Skizim Nicholas John | GRNA | Common Stock, par value $0.0001 per share | D | 26.965 | ||||||||
| 2023-06-06 | 3 | Gillian Jason Michael | GRNA | GreenLight Biosciences Holdings, PBC | D | 28.732 | ||||||||
| 2023-06-06 | 3 | FURNEAUX CAPITAL HOLDCO, LLC | GRNA | Greenlight Biosciences common stock | D | 188.134 | ||||||||
| 2023-06-02 | 3 | Sagar Rosemary | GRNA | GreenLight Biosciences Holdings, PBC | D | 208.704 | ||||||||
| 2023-06-02 | 3 | Series Greenlight 2, a separate series of BlueIO Growth LLC | GRNA | Greenlight Biosciences common stock | D | 569.423 | ||||||||
| 2023-06-02 | 3 | Series Greenlight, a separate series of BlueIO Growth LLC | GRNA | Greenlight Biosciences common stock | D | 500.890 | ||||||||
| 2023-06-02 | 3 | Velocity Financial Group, LLC | GRNA | Greenlight Biosciences common stock | D | 292.186 | ||||||||
| 2022-09-07 | 2022-06-01 | 4 | Ortega-Valle Marta | GRNA | Common Stock | D | 0,2300 | 29.798 | 7 | 29.798 | ||||
| 2022-08-15 | 2022-08-11 | 4 | Morningside Venture Investments Ltd | GRNA | Common Stock | D | 3,9200 | 3.061.224 | 12.000 | 15.919.155 | ||||
| 2022-08-15 | 2022-08-11 | 4 | BUILDERS VISION LLC by Builders Vision, LLC | GRNA | Common Stock | I | 3,9200 | 127.551 | 500 | 22.348.123 | ||||
| 2022-08-15 | 2022-08-11 | 4 | BUILDERS VISION LLC by Builders Vision, LLC | GRNA | Common Stock | I | 3,9200 | 6.377.551 | 25.000 | 22.220.572 | ||||
| 2022-08-15 | 2022-08-11 | 4 | Walker Matthew Alan by Builders Vision, LLC | GRNA | Common Stock | I | 3,9200 | 6.377.551 | 25.000 | 22.220.572 | ||||
| 2022-08-15 | 2022-08-11 | 4 | Walker Matthew Alan | GRNA | Common Stock | D | 3,9200 | 63.775 | 250 | 63.775 | ||||
| 2022-03-17 | 2022-02-02 | 4/A | Morningside Venture Investments Ltd | GRNA | Class A Common Stock | D | 10,0000 | -1.000.000 | -10.000 | 0 | ||||
| 2022-03-17 | 2022-02-02 | 4/A | Morningside Venture Investments Ltd | GRNA | Class A Common Stock | D | -12.857.931 | 0 | ||||||
| 2022-03-17 | 2022-02-02 | 4/A | Morningside Venture Investments Ltd | GRNA | Common Stock | D | 1.000.000 | 13.857.931 | ||||||
| 2022-03-17 | 2022-02-02 | 4/A | Morningside Venture Investments Ltd | GRNA | Common Stock | D | 12.857.931 | 12.857.931 | ||||||
| 2022-02-04 | 2022-02-02 | 4 | Walker Matthew Alan by Builders Vision, LLC | GRNA | Common Stock | I | 10,0000 | 1.500.000 | 15.000 | 15.843.021 | ||||
| 2022-02-04 | 2022-02-02 | 4 | Walker Matthew Alan by Builders Vision, LLC | GRNA | Common Stock | I | 14.343.021 | 14.343.021 | ||||||
| 2022-02-04 | 2022-02-02 | 4 | Keefe Susan | GRNA | Stock Option (Right to Buy) | D | 0,98 | 565.760 | 565.760 | |||||
| 2022-02-04 | 2022-02-02 | 4 | Keefe Susan | GRNA | Stock Option (Right to Buy) | D | 0,50 | 488.466 | 488.466 | |||||
| 2022-02-04 | 2022-02-02 | 4 | Schlicher Martha | GRNA | Common Stock | D | 109.220 | 109.220 | ||||||
| 2022-02-04 | 2022-02-02 | 4 | COONEY CHARLES L | GRNA | Common Stock | D | 305.314 | 305.314 | ||||||
| 2022-02-04 | 2022-02-02 | 4 | Kennedy David | GRNA | Stock Option (Right to Buy) | D | 2,61 | 66.560 | 66.560 | |||||
| 2022-02-04 | 2022-02-02 | 4 | Kennedy David | GRNA | Stock Option (Right to Buy) | D | 1,23 | 3.693 | 3.693 | |||||
| 2022-02-04 | 2022-02-02 | 4 | Kennedy David | GRNA | Stock Option (Right to Buy) | D | 1,23 | 235.992 | 235.992 | |||||
| 2022-02-04 | 2022-02-02 | 4 | OBrien Eric by Fall Line Endurance Fund, LP | GRNA | Common Stock | I | 10,0000 | 700.000 | 7.000 | 8.901.814 | ||||
| 2022-02-04 | 2022-02-02 | 4 | OBrien Eric by Fall Line Endurance Fund, LP | GRNA | Common Stock | I | 8.201.814 | 8.201.814 | ||||||
| 2022-02-04 | 2022-02-02 | 4 | KISHORE GANESH by MLS Capital Fund II, L.P. | GRNA | Common Stock | I | 10,0000 | 75.000 | 750 | 5.818.575 | ||||
| 2022-02-04 | 2022-02-02 | 4 | KISHORE GANESH by MLS Capital Fund II, L.P. | GRNA | Common Stock | I | 5.743.575 | 5.743.575 | ||||||
| 2022-02-04 | 2022-02-02 | 4 | Ortega-Valle Marta | GRNA | Stock Option (Right to Buy) | D | 0,98 | 259.584 | 259.584 | |||||
| 2022-02-04 | 2022-02-02 | 4 | Ortega-Valle Marta | GRNA | Stock Option (Right to Buy) | D | 0,98 | 247.727 | 247.727 | |||||
| 2022-02-04 | 2022-02-02 | 4 | Ortega-Valle Marta | GRNA | Stock Option (Right to Buy) | D | 0,35 | 106.098 | 106.098 | |||||
| 2022-02-04 | 2022-02-02 | 4 | Ortega-Valle Marta | GRNA | Stock Option (Right to Buy) | D | 0,28 | 105.266 | 105.266 | |||||
| 2022-02-04 | 2022-02-02 | 4 | Ortega-Valle Marta | GRNA | Stock Option (Right to Buy) | D | 0,24 | 29.798 | 29.798 | |||||
| 2022-02-04 | 2022-02-02 | 4 | Manocha Charu | GRNA | Stock Option (Right to Buy) | D | 0,98 | 116.480 | 116.480 | |||||
| 2022-02-04 | 2022-02-02 | 4 | Manocha Charu | GRNA | Stock Option (Right to Buy) | D | 0,98 | 232.960 | 232.960 | |||||
| 2022-02-04 | 2022-02-02 | 4 | Singleton Mark | GRNA | Stock Option (Right to Buy) | D | 2,61 | 126.424 | 126.424 | |||||
| 2022-02-04 | 2022-02-02 | 4 | Singleton Mark | GRNA | Stock Option (Right to Buy) | D | 1,23 | 13.399 | 13.399 | |||||
| 2022-02-04 | 2022-02-02 | 4 | Singleton Mark | GRNA | Stock Option (Right to Buy) | D | 1,23 | 192.936 | 192.936 | |||||
| 2022-02-04 | 2022-02-02 | 4 | Zarur Juan Andrey | GRNA | Stock Option (Right to Buy) | D | 0,98 | 292.649 | 292.649 | |||||
| 2022-02-04 | 2022-02-02 | 4 | Zarur Juan Andrey | GRNA | Stock Option (Right to Buy) | D | 0,98 | 1.906.944 | 1.906.944 | |||||
| 2022-02-04 | 2022-02-02 | 4 | Zarur Juan Andrey | GRNA | Stock Option (Right to Buy) | D | 0,50 | 668.830 | 668.830 | |||||
| 2022-02-04 | 2022-02-02 | 4 | Zarur Juan Andrey | GRNA | Stock Option (Right to Buy) | D | 0,50 | 1.982.609 | 1.982.609 | |||||
| 2022-02-04 | 2022-02-02 | 4 | Zarur Juan Andrey | GRNA | Stock Option (Right to Buy) | D | 0,33 | 926.330 | 926.330 | |||||
| 2022-02-04 | 2022-02-02 | 4 | Zarur Juan Andrey | GRNA | Stock Option (Right to Buy) | D | 0,35 | 70.319 | 70.319 | |||||
| 2022-02-04 | 2022-02-02 | 4 | Zarur Juan Andrey | GRNA | Common Stock | D | 896.058 | 896.058 | ||||||
| 2022-02-04 | 2022-02-02 | 4 | COBB CAROLE B | GRNA | Stock Option (Right to Buy) | D | 0,98 | 326.144 | 326.144 | |||||
| 2022-02-04 | 2022-02-02 | 4 | COBB CAROLE B | GRNA | Stock Option (Right to Buy) | D | 0,50 | 26.987 | 26.987 | |||||
| 2022-02-04 | 2022-02-02 | 4 | COBB CAROLE B | GRNA | Stock Option (Right to Buy) | D | 0,50 | 480.560 | 480.560 | |||||
| 2022-02-04 | 2022-02-02 | 4 | COBB CAROLE B | GRNA | Stock Option (Right to Buy) | D | 0,33 | 187.831 | 187.831 | |||||
| 2022-02-04 | 2022-02-02 | 4 | COBB CAROLE B | GRNA | Stock Option (Right to Buy) | D | 0,33 | 459.264 | 459.264 | |||||
| 2022-02-04 | 2022-02-02 | 4 | COBB CAROLE B | GRNA | Stock Option (Right to Buy) | D | 0,35 | 43.863 | 43.863 | |||||
| 2022-02-04 | 2022-02-02 | 4 | COBB CAROLE B | GRNA | Stock Option (Right to Buy) | D | 0,35 | 427.752 | 427.752 | |||||
| 2022-02-04 | 2022-02-02 | 4 | Khan Amin | GRNA | Stock Option (Right to Buy) | D | 1,23 | 255.687 | 255.687 | |||||
| 2022-02-04 | 2022-02-02 | 4 | Khan Amin | GRNA | Stock Option (Right to Buy) | D | 1,23 | 276.792 | 276.792 | |||||
| 2022-02-04 | 2022-02-02 | 4 | Morningside Venture Investments Ltd | ENVI | Class A Common Stock | D | 10,0000 | -1.000.000 | -10.000 | 0 | ||||
| 2022-02-04 | 2022-02-02 | 4 | Morningside Venture Investments Ltd | ENVI | Class A Common Stock | D | -12.858.188 | 0 | ||||||
| 2022-02-04 | 2022-02-02 | 4 | Morningside Venture Investments Ltd | ENVI | Common Stock | D | 1.000.000 | 13.858.188 | ||||||
| 2022-02-04 | 2022-02-02 | 4 | Morningside Venture Investments Ltd | ENVI | Common Stock | D | 12.858.188 | 12.858.188 |
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)
